Intelligent Bio Solutions... (INBS)
NASDAQ: INBS
· Real-Time Price · USD
1.35
0.07 (5.47%)
At close: May 01, 2025, 3:58 PM
1.24
-8.15%
Pre-market: May 02, 2025, 04:37 AM EDT
5.47% (1D)
| Bid | 1.23 |
| Market Cap | 9.2M |
| Revenue (ttm) | 3.03M |
| Net Income (ttm) | -10.69M |
| EPS (ttm) | 0.12 |
| PE Ratio (ttm) | 11.25 |
| Forward PE | 3.69 |
| Analyst | n/a |
| Ask | 1.5 |
| Volume | 44,711 |
| Avg. Volume (20D) | 196,427 |
| Open | 1.25 |
| Previous Close | 1.28 |
| Day's Range | 1.25 - 1.35 |
| 52-Week Range | 1.00 - 3.04 |
| Beta | 4.63 |
About INBS
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a b...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Dec 23, 2020
Employees 50
Stock Exchange NASDAQ
Ticker Symbol INBS
Website https://gbs.inc
1 month ago
-16.59%
Intelligent Bio Solutions shares are trading lower...
Unlock content with
Pro Subscription
2 months ago
-20.45%
Intelligent Bio Solutions shares are trading lower after the company announced a $2.6 million proposed public offering of common stock.
